Board of Directors |
 | David H. Murdock
Chairman of the Board (3)David H. Murdock
Chairman of the Board (3)
Mr. Murdock, 86, joined Dole as Chairman of the Board and Chief Executive Officer in July 1985, and continued as Dole’s Chief Executive Office until June 2007. Mr. Murdock was reappointed as Dole’s Chief Executive Officer in February, 2013. He has been Chairman of the Board, Chief Executive Officer and Director of Castle & Cooke, Inc., a Hawaii corporation, since October 1995 (Mr. Murdock has beneficially owned all of the capital stock of Castle & Cooke, Inc. since September 2000). Mr. Murdock... |
| | | C. Michael Carter
President, Chief Operating Officer and Director (3)C. Michael Carter
President, Chief Operating Officer and Director (3)
Mr. Carter, 69, became Dole’s Senior Vice President, General Counsel and Corporate Secretary in July 2003, Executive Vice President, General Counsel and Corporate Secretary in July 2004, President, Chief Operating Officer, General Counsel and Corporate Secretary in February 2013 in connection with the sale of Dole’s worldwide packaged foods and Asia fresh produce business to ITOCHU Corporation. Mr. Carter became a director of Dole in April 2003, resigned as a director upon the listing of the Co... |
| | | Elaine L. Chao
Director (2), (4)Elaine L. Chao
Director (2), (4)
Ms. Chao, 60, was the nation’s 24th Secretary of Labor from 2001 to 2009, the first Asian-Pacific American woman in our country’s history to be appointed to the President’s cabinet. From 1996 to 2001 and presently, Ms. Chao was a Distinguished Fellow at the Heritage Foundation, an educational and research organization based in Washington, D.C. Ms. Chao is the Chairman of the Nominating & Corporate Governance Committee as well as a member of the Corporate Compensation & Benefits Committee of Dole... |
| | | Andrew J. Conrad
Director (1), (2)Andrew J. Conrad
Director (1), (2)
Dr. Conrad, 49, became a director in July 2003. Dr. Conrad was a co-founder of the National Genetics Institute, a provider of advanced genetics testing services for blood screening, medical testing and clinical research, and has been its chief scientific officer since 1992. Dr. Conrad is Chairman of the Audit Committee and is also on the Corporate Compensation & Benefits Committee of Dole’s Board of Directors.... |
| | | David A. DeLorenzo
Director (3)David A. DeLorenzo
Director (3)
Mr. DeLorenzo, 66, was Dole’s Chief Executive Officer from June 2007 to February 2013. In February 2013, Mr. DeLorenzo stepped down from his roles as President and Chief Executive officer of Dole, and will be joining the ITOCHU Corporation to lead the acquired Dole Asia fresh and worldwide packaged foods businesses. Mr. DeLorenzo originally joined Dole in 1970. He was President of Dole Fresh Fruit Company from September 1986 to June 1992, President of Dole Food Company from July 1990 to March ... |
| | | E. Rolland Dickson, M.D.
Director (1), (4) E. Rolland Dickson, M.D.
Director (1), (4)
Dr. Dickson, 79, rejoined Dole’s Board of Directors in February 2013, having previously served as a director from April 2001 to March 2003. Dr. Dickson previously was a professor of medicine at the Mayo Medical School and director of development at the Mayo Foundation for Medical Education and Research. Dr. Dickson is internationally recognized for his leadership in the fields of liver disease and liver transplantation, and has served as a director of Poniard Pharmaceuticals, Axcan Pharma Inc., ... |
| | | Sherry Lansing
Director (4)Sherry Lansing
Director (4)
Ms. Lansing, 68, is the Founder and Chair of the Sherry Lansing Foundation, a philanthropic organization focusing on cancer research, health and education. From 1992 to 2005, she was the Chair of the Motion Picture Group of Paramount Pictures where she oversaw the release of more than 200 films, including Academy Award® winners “Forrest Gump,” “Braveheart” and “Titanic.” From 1984 to 1990, she operated her own production company, Lansing Productions, and co-founded Jaffe/Lansing Productions. In ... |
| | | Justin M. Murdock
DirectorJustin M. Murdock
Director
Mr. Murdock, 40, has been Senior Vice President of Investments of Castle & Cooke, Inc., which is wholly owned by David H. Murdock, since 2004, and prior to that its Vice President of Investments since 2001. Mr. Justin M. Murdock is also Chairman of the Board and CEO of NovaRx, a privately held clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of novel cell-based therapeutic vaccines for the treatment of cancer, a position he has held since Oc... |
| | | Dennis M. Weinberg
Director (1), (2)Dennis M. Weinberg
Director (1), (2)
Mr. Weinberg, 60, was one of the founding Directors for WellPoint (NYSE:WLP), a health benefits company. From February 2002 to May 2006, Mr. Weinberg served as President and Chief Executive Officer for ARCUS Enterprises, a WellPoint business development company. Mr. Weinberg served for nearly 20 years in a variety of CEO, Group President, and Executive Vice President positions with WellPoint and its various affiliates. Prior to WellPoint, Mr. Weinberg held a variety of business consulting positi... |
| |
(1) Audit Committee
(2) Corporate Compensation and Benefits Committee
(3) Executive Committee
(4) Nominating and Corporate Governance Committee
|
| 
|
